Substituted 1,2-Dihydrophthalazines: Potent, Selective, and Noncompetitive Inhibitors of the AMPA Receptor
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (2) , 343-346
- https://doi.org/10.1021/jm950740w
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Therapeutic potential of NMDA antagonists in neurodegenerative diseasesNeurobiology of Aging, 1994
- Structure-activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic actionBioorganic & Medicinal Chemistry Letters, 1993
- Anticonvulsant activity of glycine-site NMDA antagonists. 1. 2-carboxyl prodrugs of 5,7-dichlorokynurenic acidBioorganic & Medicinal Chemistry Letters, 1993
- A benzodiazepine recognition site associated with the non-NMDA glutamate receptorNeuron, 1993
- GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responsesNeuron, 1993
- Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat.Stroke, 1992
- Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult ratsNeuroscience Letters, 1991
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990
- Synthesis via vinyl sulfones. 18. Rapid access to a series of highly functionalized .alpha.,.beta.-unsaturated cyclopentenones. A caveat on aminospirocyclizationThe Journal of Organic Chemistry, 1987
- Ibotenic acid analogs. Synthesis and biological and in vitro activity of conformationally restricted agonists at central excitatory amino acid receptorsJournal of Medicinal Chemistry, 1984